Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 147   

Articles published

GSK 1,644.59 +26.59 (1.64%)
price chart
GlaxoSmithKline plc (GSK) Price Target Increased to GBX 1720 by Analysts at ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) had its price target boosted by equities researchers at Deutsche Bank AG from GBX 1,700 ($22.12) to GBX 1,720 ($22.38) in a research note issued on Friday, May 12th.
Its time to give a fresh look to GlaxoSmithKline plc (GSK) and Infosys Limited ...
Shares of GlaxoSmithKline plc (NYSE:GSK) observed rebound of 16.4% since bottoming out at $37.2 on Dec. 08, 2016. Meanwhile, due to an ongoing pressure which caused a decline of almost -0.21% in the past five days, the stock price is now up 12.44% ...
Right time to invest? - GlaxoSmithKline plc (GSK), Telefonaktiebolaget LM ...
Shares of GlaxoSmithKline plc (NYSE:GSK) observed rebound of 15.46% since bottoming out at $37.2 on Dec. 08, 2016. Meanwhile, due to an ongoing pressure which caused a decline of almost -0.65% in the past five days, the stock price is now up 11.53% ...
GlaxoSmithKline plc (GSK) Rating Reiterated by JPMorgan Chase & Co.
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “neutral” rating restated by research analysts at JPMorgan Chase & Co.
GlaxoSmithKline plc (GSK) Rating Reiterated by Beaufort Securities  The Cerbat Gem
GlaxoSmithKline plc (GSK) Shares Sold by Forward Management LLC  Stock Observer
AstraZeneca Sues Executive After Rival Glaxo Lures Him Away
AstraZeneca Plc filed a lawsuit in a London court against former executive Luke Miels saying he's in violation of his employment agreement, four months after rival drugmaker GlaxoSmithKline Plc announced it was poaching him to run its largest business.
What is the Street Saying About GlaxoSmithKline PLC (NYSE:GSK)?
Investors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability.
Should You Buy, Sell, Or Hold? – Broadcom Limited (AVGO), GlaxoSmithKline plc ...
Shares of Broadcom Limited (NASDAQ:AVGO) are making a strong comeback as they have jumped 66.26% since bottoming out at $142.27 on Jun. 27, 2016.
GlaxoSmithKline plc (GSK) PT Set at GBX 1720 by Deutsche Bank AG
GlaxoSmithKline plc logo Deutsche Bank AG set a GBX 1,720 ($22.20) target price on GlaxoSmithKline plc (LON:GSK) in a research note released on Tuesday, April 18th.
Independent Portfolio Consultants Inc. Has $548000 Position in ...  The Cerbat Gem
The Jefferies Group LLC Reiterates “Buy” Rating for GlaxoSmithKline plc (GSK ...  BangaloreWeekly
Form 25-NSE GLAXOSMITHKLINE PLC Filed by: NEW YORK STOCK EXCHANGE LLC
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. X0203 0000876661 NEW YORK STOCK EXCHANGE LLC 1131399 GLAXOSMITHKLINE PLC 001-15170. GSK House 980 Great West Road Brentford TW8 9GS.
Earnings Growth Research: GlaxoSmithKline plc (GSK), Amarin Corporation plc (AMRN)
Shares of GlaxoSmithKline plc (NYSE:GSK) are on a recovery track as they have regained 20.25% since bottoming out at $37.2 on Dec. 08, 2016.